We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.33%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$107B
AUM Growth
-$4.74B
(-4.2%)
Cap. Flow
-$4.5B
Cap. Flow
% of AUM
-4.19%
Top 10 Holdings %
Top 10 Hldgs %
16.64%
Holding
4,289
New
314
Increased
1,937
Reduced
1,469
Closed
342
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$731M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$547M |
| 3 |
AABA
Altaba Inc
AABA
|
+$213M |
| 4 |
QEP
QEP RESOURCES, INC.
QEP
|
+$196M |
| 5 |
Alibaba
BABA
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.54B |
| 2 |
XIV
VelocityShares Daily Inverse VIX Short Term ETN
XIV
|
+$959M |
| 3 |
Citigroup
C
|
+$339M |
| 4 |
Apple
AAPL
|
+$337M |
| 5 |
EQT Corp
EQT
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.27% |
| 2 | Financials | 11.39% |
| 3 | Healthcare | 9.26% |
| 4 | Consumer Discretionary | 6.73% |
| 5 | Industrials | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Seres Therapeutics
MCRB
$46.8M
| $103K | ﹤0.01% |
704
+180
| +34% | +$34.5K |
|
3652
AXT Inc
AXTI
$3.95B
| $101K | ﹤0.01% |
13,972
+3,172
| +29% | +$25.8K |
|
|
CMRX
3653
DELISTED
Chimerix, Inc.
CMRX
| $100K | ﹤0.01% |
19,198
+1,318
| +7% | +$6.68K |
|
3654
Cytosorbents Corp
CTSO
$22.7M
| $98K | ﹤0.01% |
13,868
-10,280
| -43% | -$77.7K |
|
3655
Kopin
KOPN
$652M
| $98K | ﹤0.01% |
31,534
+8,725
| +38% | +$29.4K |
|
|
GFN
3656
DELISTED
General Finance Corporation
GFN
| $98K | ﹤0.01% |
+13,562
| New | +$97.1K |
|
3657
IDT Corp
IDT
$1.64B
| $97K | ﹤0.01% |
15,445
+501
| +3% | +$4.58K |
|
|
NSTG
3658
DELISTED
NanoString Technologies, Inc.
NSTG
| $97K | ﹤0.01% |
+12,906
| New | +$93.6K |
|
|
ACGN
3659
DELISTED
Aceragen Inc
ACGN
| $96K | ﹤0.01% |
385
+86
| +29% | +$23.6K |
|
|
GCAP
3660
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $94K | ﹤0.01% |
14,028
+1,531
| +12% | +$11.5K |
|
3661
Prospect Capital
PSEC
$1.07B
| $93K | ﹤0.01% |
+14,177
| New | +$94.7K |
|
|
HZN
3662
DELISTED
Horizon Global Corporation
HZN
| $93K | ﹤0.01% |
+11,342
| New | +$114K |
|
3663
CryoPort
CYRX
$761M
| $92K | ﹤0.01% |
+10,719
| New | +$94.7K |
|
3664
Teekay Tankers
TNK
$2.75B
| $92K | ﹤0.01% |
9,616
+2,235
| +30% | +$22.2K |
|
|
VRAY
3665
DELISTED
ViewRay, Inc.
VRAY
| $92K | ﹤0.01% |
+14,343
| New | +$120K |
|
3666
Ardelyx
ARDX
$1.22B
| $91K | ﹤0.01% |
17,880
+5,468
| +44% | +$34.1K |
|
3667
Ardmore Shipping
ASC
$710M
| $91K | ﹤0.01% |
+12,077
| New | +$91.7K |
|
|
CCEC
3668
Capital Clean Energy Carriers
CCEC
$1.34B
| $90K | ﹤0.01% |
4,112
+850
| +26% | +$19.6K |
|
|
EGLE
3669
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $90K | ﹤0.01% |
2,589
-252
| -9% | -$8.77K |
|
3670
Goldgroup Mining Inc.
GORO
$157M
| $89K | ﹤0.01% |
19,655
+4,408
| +29% | +$19.8K |
|
3671
Standard BioTools
LAB
$340M
| $89K | ﹤0.01% |
15,316
+2,292
| +18% | +$15.1K |
|
3672
Minerva Neurosciences
NERV
$185M
| $89K | ﹤0.01% |
1,768
+137
| +8% | +$6.58K |
|
|
3673
PUT
Prospect Capital
PSEC
$1.07B
| $89K | ﹤0.01% |
13,600
-1,052,800
| -99% | -$7.03M |
|
|
NEOS
3674
DELISTED
Neos Therapeutics, Inc
NEOS
| $88K | ﹤0.01% |
+10,613
| New | +$101K |
|
3675
Mitek Systems
MITK
$754M
| $87K | ﹤0.01% |
11,628
-1,093
| -9% | -$8.9K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2018 Portfolio in Review
As of Q1 2018, Credit Suisse held 4,289 positions worth $107B, down 4.2% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $4.5B in Q1 2018, closing 342 positions and reducing 1,469 holdings. Its most notable exit was VelocityShares Daily Inverse VIX Short Term ETN, an estimated $959M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Credit Suisse opened a new position in Cambria Shareholder Yield ETF worth $75.4M.
- Credit Suisse's largest Q1 2018 buy was Cambria Shareholder Yield ETF: 2,000,000 shares worth $75.4M.
- Credit Suisse added most to iShares Core S&P Mid-Cap ETF in Q1 2018, an estimated $731M increase.
- Credit Suisse's biggest Q1 2018 reduction was UnitedHealth, cutting an estimated $1.54B.
- Credit Suisse fully exited VelocityShares Daily Inverse VIX Short Term ETN in Q1 2018, selling an estimated $959M.
- Credit Suisse's ten largest holdings make up 17% of its $107B portfolio in Q1 2018.
- Credit Suisse opened 314 new positions and closed 342 in Q1 2018.
- Credit Suisse's portfolio value fell 4.2% quarter-over-quarter to $107B.
Based on Credit Suisse's 13F filing for Q1 2018, filed 15 May 2018.